Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: A phase I report
- 31 October 2003
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 126 (4) , 1168-1173
- https://doi.org/10.1016/s0022-5223(03)00977-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Should En Bloc Esophagectomy Be the Standard of Care for Esophageal Carcinoma?Annals of Surgery, 2001
- Curative Resection for Esophageal AdenocarcinomaAnnals of Surgery, 2001
- A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junctionCancer, 2001
- N1 esophageal carcinoma: The importance of staging and downstagingThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Neoadjuvant Chemoradiation Followed by Surgery for Resectable Esophageal CancerPublished by Springer Nature ,2000
- Resectable Esophageal Carcinoma: Local Control with Neoadjuvant Chemotherapy and Radiation TherapyRadiology, 1999
- A Comparison of Multimodal Therapy and Surgery for Esophageal AdenocarcinomaNew England Journal of Medicine, 1996
- Tumors of the esophagogastric junction: long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of ptnm classificationThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report.Journal of Clinical Oncology, 1993
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992